125 related articles for article (PubMed ID: 8758598)
1. [Pharmacological therapeutic prospects of cerebral vasospasm].
Hans P
Ann Fr Anesth Reanim; 1996; 15(3):374-81. PubMed ID: 8758598
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological treatment of vasospasm in subarachnoid hemorrhage].
Melon E; Rimaniol JM
Ann Fr Anesth Reanim; 1996; 15(3):366-73. PubMed ID: 8758597
[TBL] [Abstract][Full Text] [Related]
3. U74389G prevents vasospasm after subarachnoid hemorrhage in dogs.
Macdonald RL; Bassiouny M; Johns L; Sajdak M; Marton LS; Weir BK; Hall ED; Andrus PK
Neurosurgery; 1998 Jun; 42(6):1339-45; discussion 1345-6. PubMed ID: 9632194
[TBL] [Abstract][Full Text] [Related]
4. Effect of intrathecal superoxide dismutase and catalase on oxyhemoglobin-induced vasospasm in monkeys.
Macdonald RL; Weir BK; Runzer TD; Grace MG; Poznansky MJ
Neurosurgery; 1992 Apr; 30(4):529-39. PubMed ID: 1584351
[TBL] [Abstract][Full Text] [Related]
5. New developments in the treatment of SAH-induced cerebral vasospasm.
Axone; 1993 Sep; 15(1):25. PubMed ID: 8274392
[No Abstract] [Full Text] [Related]
6. Effect of BQ-123 and tissue plasminogen activator on vasospasm after subarachnoid hemorrhage in monkeys.
Kim CJ; Bassiouny M; Macdonald RL; Weir B; Johns LM
Stroke; 1996 Sep; 27(9):1629-33. PubMed ID: 8784140
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.
Haley EC; Kassell NF; Alves WM; Weir BK; Hansen CA
J Neurosurg; 1995 May; 82(5):786-90. PubMed ID: 7714603
[TBL] [Abstract][Full Text] [Related]
8. The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage.
Findlay JM; Weir BK; Kanamaru K; Grace M; Baughman R
Neurosurgery; 1990 Feb; 26(2):201-6. PubMed ID: 2106630
[TBL] [Abstract][Full Text] [Related]
9. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Findlay JM; Macdonald RL; Weir BK
Cerebrovasc Brain Metab Rev; 1991; 3(4):336-61. PubMed ID: 1772740
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.
Lanzino G; Kassell NF; Dorsch NW; Pasqualin A; Brandt L; Schmiedek P; Truskowski LL; Alves WM
J Neurosurg; 1999 Jun; 90(6):1011-7. PubMed ID: 10350245
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage.
Seifert V; Eisert WG; Stolke D; Goetz C
Neurosurgery; 1989 Oct; 25(4):590-8. PubMed ID: 2507953
[TBL] [Abstract][Full Text] [Related]
12. Effect of the nonglucocorticoid 21-aminosteroid U74006F experimental cerebral vasospasm.
Vollmer DG; Kassell NF; Hongo K; Ogawa H; Tsukahara T
Surg Neurol; 1989 Mar; 31(3):190-4. PubMed ID: 2922661
[TBL] [Abstract][Full Text] [Related]
13. Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage.
Jang YG; Ilodigwe D; Macdonald RL
Neurocrit Care; 2009; 10(1):141-7. PubMed ID: 18810661
[TBL] [Abstract][Full Text] [Related]
14. Lazaroids and deferoxamine attenuate the intracellular effects of oxyhaemoglobin in vascular smooth muscle.
Vollrath B; Chan P; Findlay M; Cook D
Cardiovasc Res; 1995 Oct; 30(4):619-26. PubMed ID: 8575010
[TBL] [Abstract][Full Text] [Related]
15. The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog.
Hirose H; Ide K; Sasaki T; Takahashi R; Kobayashi M; Ikemoto F; Yano M; Nishikibe M
Eur J Pharmacol; 1995 Apr; 277(1):77-87. PubMed ID: 7635177
[TBL] [Abstract][Full Text] [Related]
16. Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand.
Kassell NF; Haley EC; Apperson-Hansen C; Alves WM
J Neurosurg; 1996 Feb; 84(2):221-8. PubMed ID: 8592224
[TBL] [Abstract][Full Text] [Related]
17. The effect and management of delayed vasospasm after aneurysmal subarachnoid hemorrhage.
Dorsch NW
Neurol Med Chir (Tokyo); 1998; 38 Suppl():156-60. PubMed ID: 10234999
[TBL] [Abstract][Full Text] [Related]
18. [Cerebral vasospasm caused by subarachnoid hemorrhage].
Paoletti P; Gaetani P; Spanu G; Rodriguez y Baena R
Minerva Med; 1986 Jun; 77(24):1071-7. PubMed ID: 3088488
[TBL] [Abstract][Full Text] [Related]
19. Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients.
Kodama N; Sasaki T; Kawakami M; Sato M; Asari J
Surg Neurol; 2000 Feb; 53(2):110-7; discussion 117-8. PubMed ID: 10713187
[TBL] [Abstract][Full Text] [Related]
20. Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans.
Thomas JE; Rosenwasser RH
Neurosurgery; 1999 Jan; 44(1):48-57; discussion 57-8. PubMed ID: 9894963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
